These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30460622)

  • 1. Authors' Reply to Angelis and Kanavos: "Does MCDA Trump CEA?".
    Campillo-Artero C; Puig-Junoy J; Culyer AJ
    Appl Health Econ Health Policy; 2019 Feb; 17(1):125. PubMed ID: 30460622
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: "Does MCDA Trump CEA?".
    Angelis A; Kanavos P
    Appl Health Econ Health Policy; 2019 Feb; 17(1):123-124. PubMed ID: 30467732
    [No Abstract]   [Full Text] [Related]  

  • 3. Does MCDA Trump CEA?
    Campillo-Artero C; Puig-Junoy J; Culyer AJ
    Appl Health Econ Health Policy; 2018 Apr; 16(2):147-151. PubMed ID: 29468578
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple criteria decision analysis for health technology assessment.
    Thokala P; Duenas A
    Value Health; 2012 Dec; 15(8):1172-81. PubMed ID: 23244821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of MCDA in HTA: Great Potential, but More Effort Needed.
    Marsh KD; Sculpher M; Caro JJ; Tervonen T
    Value Health; 2018 Apr; 21(4):394-397. PubMed ID: 29680094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
    Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
    Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge Translation in Practice: Exploring the Potential Use of MCDA in Central America and the Caribbean.
    Espinoza MA; Rojas R; Acosta de Patiño H
    Value Health Reg Issues; 2018 Dec; 17():148-149. PubMed ID: 30184512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion.
    Diaby V; Goeree R; Hoch J; Siebert U
    Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):13-9. PubMed ID: 25267699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.
    Marsh K; IJzerman M; Thokala P; Baltussen R; Boysen M; Kaló Z; Lönngren T; Mussen F; Peacock S; Watkins J; Devlin N;
    Value Health; 2016; 19(2):125-37. PubMed ID: 27021745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets.
    Brixner D; Maniadakis N; Kaló Z; Hu S; Shen J; Wijaya K
    Value Health Reg Issues; 2017 Sep; 13():1-6. PubMed ID: 29073981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International experiences in multicriteria decision analysis (MCDA) for evaluating orphan drugs: a scoping review.
    Lasalvia P; Prieto-Pinto L; Moreno M; Castrillón J; Romano G; Garzón-Orjuela N; Rosselli D
    Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):409-420. PubMed ID: 31210065
    [No Abstract]   [Full Text] [Related]  

  • 12. Realizing the "Great Potential" of MCDA in HTA.
    Hall W; Mitton C; Levy A
    Value Health; 2018 Dec; 21(12):1355-1356. PubMed ID: 30502777
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force.
    Thokala P; Devlin N; Marsh K; Baltussen R; Boysen M; Kalo Z; Longrenn T; Mussen F; Peacock S; Watkins J; Ijzerman M
    Value Health; 2016 Jan; 19(1):1-13. PubMed ID: 26797229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treacle and Smallpox: Two Tests for Multicriteria Decision Analysis Models in Health Technology Assessment.
    Morton A
    Value Health; 2017 Mar; 20(3):512-515. PubMed ID: 28292498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PATIENT-CENTERED DECISION MAKING: LESSONS FROM MULTI-CRITERIA DECISION ANALYSIS FOR QUANTIFYING PATIENT PREFERENCES.
    Marsh K; Caro JJ; Zaiser E; Heywood J; Hamed A
    Int J Technol Assess Health Care; 2018 Jan; 34(1):105-110. PubMed ID: 29277175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.
    Castro Jaramillo HE; Goetghebeur M; Moreno-Mattar O
    Int J Technol Assess Health Care; 2016 Jan; 32(4):307-314. PubMed ID: 27691990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting.
    Angelis A; Montibeller G; Hochhauser D; Kanavos P
    BMC Med Inform Decis Mak; 2017 Oct; 17(1):149. PubMed ID: 29073892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transparent interactive decision interrogator-reply to letter to the editor by Michael Coory.
    Bujkiewicz S; Sutton AJ; Abrams KR; Cooper NJ; Spiegelhalter DJ
    Value Health; 2013; 16(1):216-7. PubMed ID: 23337235
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA.
    Mühlbacher AC; Kaczynski A
    Appl Health Econ Health Policy; 2016 Feb; 14(1):29-40. PubMed ID: 26519081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.